![FasterCures Quarterly Update: October 2022](/themes/custom/milken_emulsify/images/default-search-thumbnail.png)
FasterCures Quarterly Update: October 2022
![FinTech in Focus — October 18, 2022](/themes/custom/milken_emulsify/images/default-search-thumbnail.png)
FinTech in Focus — October 18, 2022
![Center for the Future of Aging: Fall 2022 Newsletter](/themes/custom/milken_emulsify/images/default-search-thumbnail.png)
Center for the Future of Aging: Fall 2022 Newsletter
![Web3, Sensible Regulation, and Asia Pacific's Global Competitiveness](/themes/custom/milken_emulsify/images/default-search-thumbnail.png)
Web3, Sensible Regulation, and Asia Pacific's Global Competitiveness
![Tech Regulation Digest: GDPR Fines Increasing, but Big Tech Companies Avoid Maximum Fines](/themes/custom/milken_emulsify/images/default-search-thumbnail.png)
Tech Regulation Digest: GDPR Fines Increasing, but Big Tech Companies Avoid Maximum Fines
![FinTech in Focus — October 4, 2022](/themes/custom/milken_emulsify/images/default-search-thumbnail.png)
FinTech in Focus — October 4, 2022
![Center for Public Health: Fall 2022](/themes/custom/milken_emulsify/images/default-search-thumbnail.png)
Center for Public Health: Fall 2022
![PLENARY - Molecule to man (and woman): Speeding translation to human trials](/sites/default/files/oembed_thumbnails/sS5R1cWGqHTPHnRqQsBU9c8CtjhdeNTOGdOnX_ThyNA.jpg)
PLENARY - Molecule to man (and woman): Speeding translation to human trials
![PANEL - Tech transfer 2.0: Innovation in university commercialization](/sites/default/files/oembed_thumbnails/qIKzTSsV6uSrEdiX05UtrDS5CbOejoUuiPEiqBtExYk.jpg)
PANEL - Tech transfer 2.0: Innovation in university commercialization
![PANEL - Social Media Changing Research Norms](/sites/default/files/oembed_thumbnails/54kx10Rh8aJ68-fPDHVAf89QKy4_CHSdMgY3PF5w5Jc.jpg)
PANEL - Social Media Changing Research Norms
![PANEL - Optimists only - Is life sciences still a good investment?](/sites/default/files/oembed_thumbnails/nl0U3QQ_xzhDnrvwY1pJxnmBjGsSfYhYHQqgXAvSlbo.jpg)